F Markus Leweke, MD, MA
Affiliations: | 1999-2009 | Psychiatry and Psychotherapy | University of Cologne, Köln, Nordrhein-Westfalen, Germany |
| 2009- | Central Institute of Mental Health | Ruprecht-Karls-University Heidelberg, Heidelberg, Baden-Württemberg, Germany |
Google:
"F Leweke"Parents
Sign in to add mentor| Uwe Heinemann | grad student | 1987-1993 | University of Cologne (Neurotree) |
| Hinderk M. Emrich | post-doc | 1993-1996 | Medizinische Hochschule Hannover |
| Christian E. Elger | post-doc | 1996-1997 | Bonn University (Neurotree) |
Children
Sign in to add trainee| Cathrin Rohleder | grad student | 2008-2012 | University of Cologne |
| Juliane K. Mueller | post-doc | Central Institute of Mental Health, Ruprecht-Karls University Heidelberg | |
| Dagmar Koethe | post-doc | 2001-2006 | University of Cologne |
Collaborators
Sign in to add collaborator| Daniele Piomelli | collaborator | 1998- | (Neurotree) |
| Andreas Meyer-Lindenberg | collaborator | 2009- | (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Couttas TA, Boost C, Pahlisch F, et al. (2024) Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers. Bmj Mental Health. 27 |
| Jieu B, Sykorova EB, Rohleder C, et al. (2024) Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol. Psychiatry Research. 339: 116005 |
| Allwright M, Guennewig B, Hoffmann AE, et al. (2024) ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids. Scientific Reports. 14: 4375 |
| Dammann I, Rohleder C, Leweke FM. (2024) Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical Review. Pharmacopsychiatry |
| Kroll SL, Hulka LM, Kexel AK, et al. (2023) Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density. Translational Psychiatry. 13: 325 |
| Hickie IB, Iorfino F, Rohleder C, et al. (2023) EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disorders. Bmj Open. 13: e072082 |
| Koethe D, Rohleder C, Kracht L, et al. (2023) Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state. Frontiers in Psychiatry. 14: 1088459 |
| Carpenter JS, Zmicerevska N, Crouse JJ, et al. (2022) Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial. Bmj Open. 12: e056298 |
| Heres S, Cordes J, Feyerabend S, et al. (2022) Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia. Schizophrenia Bulletin |
| Couttas TA, Jieu B, Rohleder C, et al. (2022) Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review. Frontiers in Psychiatry. 13: 885904 |